ZNF740 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.415900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.479800E-01
Normal-vs-Stage2
2.046400E-01
Normal-vs-Stage3
3.972400E-02
Normal-vs-Stage4
7.528000E-02
Stage1-vs-Stage2
6.358100E-03
Stage1-vs-Stage3
4.399600E-02
Stage1-vs-Stage4
1.100990E-01
Stage2-vs-Stage3
1.594000E-01
Stage2-vs-Stage4
5.527600E-01
Stage3-vs-Stage4
4.719000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.023200E-03
Normal-vs-AfricanAmerican
7.714300E-02
Normal-vs-Asian
1.480420E-01
Caucasian-vs-AfricanAmerican
8.162800E-01
Caucasian-vs-Asian
5.328000E-02
AfricanAmerican-vs-Asian
7.644500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.760900E-03
Normal-vs-Female
2.225000E-03
Male-vs-Female
9.815000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.080800E-01
Normal-vs-Age(41-60Yrs)
2.606600E-01
Normal-vs-Age(61-80Yrs)
1.619000E-03
Normal-vs-Age(81-100Yrs)
4.027900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.823200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.183700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.347400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.307900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.219200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.917600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.708350E-01
Normal-vs-Daily Drinker
6.443200E-03
Normal-vs-Weekly Drinker
3.317900E-03
Normal-vs-Occasional Drinker
2.298800E-01
Normal-vs-Social Drinker
6.474200E-02
Non Drinker-vs-Daily Drinker
2.918600E-01
Non Drinker-vs-Weekly Drinker
9.366400E-01
Non Drinker-vs-Occasional Drinker
1.056790E-01
Non Drinker-vs-Social Drinker
3.566300E-02
Daily Drinker-vs-Weekly Drinker
3.530400E-01
Daily Drinker-vs-Occasional Drinker
6.271200E-01
Daily Drinker-vs-Social Drinker
2.675000E-01
Weekly Drinker-vs-Occasional Drinker
1.403820E-01
Weekly Drinker-vs-Social Drinker
7.747700E-02
Occasional Drinker-vs-Social Drinker
4.547000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.536400E-01
Normal-vs-Grade 2
7.945400E-01
Normal-vs-Grade 3
7.611400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.130100E-02
Grade 1-vs-Grade 3
1.242620E-01
Grade 1-vs-Grade 4
3.536400E-01
Grade 2-vs-Grade 3
5.515000E-01
Grade 2-vs-Grade 4
7.945400E-01
Grade 3-vs-Grade 4
7.611400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.862770E-01
Normal-vs-NonDiabetic
2.222600E-03
Diabetic-vs-NonDiabetic
3.748200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.968230E-01
Normal-vs-NoPancreatitis
1.422450E-03
Pancreatitis-vs-NoPancreatitis
7.755400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.004000E-02
Normal-vs-N1
2.083000E-01
N0-vs-N1
5.879600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.757600E-01
Normal-vs-TP53-NonMutant
1.200760E-01
TP53-Mutant-vs-TP53-NonMutant
5.978600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
